MedPath

Assessment of Sleep Disturbance in Alzheimer Disease

Not Applicable
Completed
Conditions
Alzheimer Disease
Registration Number
NCT00831298
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Brief Summary

The purpose of this study is to study circadian rhythms, or daily cycles of sleep, wake, and activity. The investigators hope to learn how disturbed sleep in Alzheimer's Disease relates to changes in activity cycles, and how sleep disturbances may affect your daytime alertness.

This project selects patients suffering from memory problems, or voluntary to be in our Control Group. There are three parts to this study: Sleep Diaries, Behavioral Questionnaire, and Activity Recordings

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • alzheimer disease
  • MMSE > 20
  • over 65 years old
Exclusion Criteria
  • new psychotropic drug treatment
  • patient unable to do neuropsychologic tests

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
assessment of apathyat day 0, just after inclusion
Secondary Outcome Measures
NameTimeMethod
assessment of sleep disturbanceduring a week, between day 0 and day 7
determine a genetic relationship between sleep disturbance and alzheimer diseaseafter all genetic analyses of the study

Trial Locations

Locations (1)

Centre Mémoire de Ressources et de Recherche, CHU de Nice

🇫🇷

Nice, France

Centre Mémoire de Ressources et de Recherche, CHU de Nice
🇫🇷Nice, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.